Invivyd, Inc. Common Stock

Go to Invivyd, Inc. Common Stock Website

$0.72

-0.01 (-0.80%)
Live
Previous Close

$0.728

Day Range

$0.7204 - $0.7717

Previous Day Range

$0.7147 - $0.739999

Market Cap

$87.8 million USD

Day Vol.

886631

Previous Day Vol.

255409

Currency

USD

Primary Exchange

Nasdaq

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Invivyd reported strong Q4 2024 revenue growth for its COVID-19 antibody PEMGARDA, and positive Phase 1 data for its next-generation candidate VYD2311. The company aims to achieve near-term profitability and continues to advance its pipeline.

Related tickers: IVVD.

Read Full Article

Invivyd, a biopharmaceutical company, announced its participation in the Guggenheim Securities Healthcare Innovation Conference, where it will host a fireside chat and 1x1 investor meetings.

Related tickers: IVVD.

Read Full Article
Trending Tickers

Please sign in to view